Dubai: Scientists, vaccine developers, humanitarians, and decision makers from around the world will come together to discuss the best vaccines to use, and develop appropriate plans for global distribution and pricing.
The COVID-19 Vaccine Forum, hosted by the King Abdullah International Medical Research Center (KAIMRC) in Riyadh, is a key event as it provides a hub for leading COVID-19 vaccine scientists, regulators, developers, and distributors to learn about COVID-19 vaccines in development.
9
number of vaccines in Phase II–III trialsIn attendance will be top vaccine scientists from Harvard University Medical School, Stanford University School of Medicine, Baylor College of Medicine, University of Oxford, Imperial College London, The Chinese Academy of Sciences, Russian Academy of Sciences, Jazan University, Imam Abdulrahman Bin Faisal University, King Abdullah International Medical Research Center, King Fahad Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Nova Southeastern University, will present at the conference.
Representatives from Janssen, Zhifei Biological, Moderna, Inovio Pharmaceuticals, and the US National Institutes of Health will report on progress in developing COVID-Vaccines.
"The COVID-19 Vaccine Forum is one of the most important healthcare events this year." said Dr. Bandar Al Knawy, MD, FRCPC, Chief Executive Officer, Ministry of National Guard-Health Affairs, and President, King Saud Bin Abdulaziz University for Health Sciences. "It aims to bring together leaders in the field of COVID-19 vaccine development and production, health institutions, academic institutions, businesses and world organizations to discuss the latest updates on COVID-19 vaccine development and availability to the public."
“The event is unique and significant, enabling the scientific community, health workers, governmental and non-governmental institutions and the public to be informed regarding the progress of COVID-19 vaccines, and discuss concerns and issues,” said Dr. Ahmed Alaskar Executive Director, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs, and President of 11th KAIMRC Annual Forum for Medical Research.
“We thank all the prominent speakers who are presenting during the forum, the organizing committee, the collaborators and sponsors who made it possible”.
The current COVID-19 pandemic is one of the most severe pandemics in history. The present situation is unprecedented. As of October 2020, over 40 million people have been infected and over a million people have died from COVID-19. No previous pandemics have shut down the planet as COVID-19 has.
More than 4 billion people in more than 90 countries have been asked or ordered to stay at home by their governments.
Since the pandemic emerged in China in December 2019 there have been global efforts to limit the spread of the disease. People around the world have demonstrated remarkable solidarity. Scientists have shared data and resources to help accelerate discovery and development of therapies and vaccines.
Vaccine numbers
There are currently 321 vaccine candidates in development. No candidate has completed clinical trials to prove safety and efficacy, however, there are 42 vaccines in clinical research, 33 vaccines in Phase I–II trials, and 9 vaccines in Phase II–III trials.
321
number of vaccine candidates in developmentIn addition to reviewing the latest vaccine data with top vaccine developers, the Bill & Melinda Gates Foundation, the Bring Hope Humanitarian Foundation, and the Coalition for Epidemic Preparedness Innovations (CEPI), will present their plans for distributing the vaccines to people in need in all parts of the world.
